Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
Roche (OTCQX:RHHBY) is looking to boost its presence in the booming weight-loss market through an exclusive collaboration and ...
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback